Epigenetic sperm quality testing for predicting fertility treatment success: a real-world and multi-site analysis
This real-world analysis was limited by the availability of detailed clinical and phenotypic data, which may introduce potential confounders. Nevertheless, the findings highlight the clinical value of epigenetic sperm assessment as part of male fertility evaluation and support its potential to guide more effective, personalized fertility treatment pathways.
Authors
- Kristin Brogaard (ORCID: https://orcid.org/0000-0003-3479-9917)
- Jordan Kassab
- L.J. Hansard
- S.B. Hudson
- Carrie E. Bedient
- K. Kaskar
- Kaylen M. Silverberg
- Valerie I. Shavell
- R.H. Miller (ORCID: https://orcid.org/0000-0003-1674-7929)
- Kristin Van Heertum
- Madeline Kaye
- Nirvika Singh
- Bryce Daines
- Lipshultz Li
- Abby C Eblen
- Andrew Olson
- Mili Thakur
- Lorry Schneider
- Alexis Reynolds
- Matthew VerMilyea
- Derek Petersen
- Meghan Smith
- Lakingya Robinson
- Emma Giuliani
- Amy Schutt
Institutions
- Brigham Young University (US)
- Grand Rapids Community College (US)
- Baylor College of Medicine (US)
- Deseret Laboratories (United States) (US)
- Texas Fertility Center (US)
- Fertility Center of Las Vegas (US)
- Grand Rapids Public Museum (US)
- Nashville Oncology Associates (US)
- Ovation Fertility (US)
- Shady Grove Fertility Center (US)
Publication Details
- Journal
- Journal of Assisted Reproduction and Genetics
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1007/s10815-025-03791-0
- Primary Topic
- Sperm and Testicular Function
- Type
- article
- Field-Weighted Citation Impact
- 0.00